Medication eligibility and outcomes depend on individual clinical evaluation
Why GLP-1 Therapy Works Better with a Registered Dietitian Amy McCallister May 4 3 min read GLP-1 medications have changed the landscape of weight management
For individuals who want visceral fat reduction without the systemic growth hormone effects, or who have contraindications to growth hormone elevation, AOD-9604 may be preferable
In a head-to-head trial in adults with obesity or overweight without diabetes, tirzepatide, the active ingredient in Mounjaro and Zepbound led to greater average weight loss than semaglutide over 72 weeks.However, there are various factors to consider when determining which medication is the best fit for an individual's unique needs including cost and insurance coverage, overall health, side effects, and how well the medication aligns with one's lifestyle and goals
At the highest dose of 15mg, mean weight loss reached 20.9 percent over 72 weeks
Hayes, S